Lamdong Pharmaceutical JSC (HNX:LDP)
8,000.00
+100.00 (1.27%)
At close: Aug 12, 2026
HNX:LDP Revenue
Lamdong Pharmaceutical JSC had revenue of 69.21B VND in the quarter ending June 30, 2026, with 38.35% growth. This brings the company's revenue in the last twelve months to 262.06B, up 11.12% year-over-year. In the year 2025, Lamdong Pharmaceutical JSC had annual revenue of 243.91B with 11.91% growth.
Revenue (ttm)
262.06B
Revenue Growth
+11.12%
P/S Ratio
0.57
Revenue / Employee
1.00B
Employees
261
Market Cap
149.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 243.91B | 25.95B | 11.91% |
| Dec 31, 2024 | 217.96B | 31.96B | 17.18% |
| Dec 31, 2023 | 186.00B | -1.41B | -0.75% |
| Dec 31, 2022 | 187.41B | 25.51B | 15.76% |
| Dec 31, 2021 | 161.90B | -217.76B | -57.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 979.05B |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.31B |
| Central Pharmaceutical Joint Stock Company No3 | 515.53B |
| Mediplantex National Pharmaceutical JSC | 291.40B |
| SPM Corporation | 217.45B |
| Cai Lay Veterinary Pharmaceutical JSC | 153.97B |